Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 965 in Teva Pharmaceutical Industries

  1. Dr Reddy's to shift some bulk drugs from AP unitRead the original story

    Yesterday | DNA India

    ... US FDA withdrew its tentative approval in November last year. On the other hand, Israel-based Teva Pharmaceutical Industries this week received approval of first generic equivalent to Nexium in the US market. The annual sales of the drug is ...

    Comment?

  2. Now Available: Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis ReviewRead the original story

    Thursday | PR-inside.com

    ... disorders, such as Gaucher disease and Fabry disease. The company partners with Pfizer, Teva Pharmaceutical Industries and Fundacao Oswaldo Cruz. Protalix is headquartered in Carmiel, Israel. Full Report Details at - ...

    Comment?

  3. Invest like a legend: Seymour SchulichRead the original story w/Photo

    Wednesday Jan 28 | The Globe and Mail

    ... stocks. Birchcliff and San Juan Basin Royalty Trust are my gas plays. I also own shares in Teva Pharmaceutical Industries, the world's largest generics company. I own physical gold through the Royal Canadian Mint's bullion exchange-traded receipts. ...

    Comment?

  4. Europe Seeks Drug SuspensionsRead the original story

    Wednesday Jan 28 | Chemical and Engineering News

    ... the European Commission. The list of manufacturers affected includes industry leaders Sandoz, Teva Pharmaceutical Industries, and Mylan. Essential drugs that aren't available from alternate suppliers will not be removed from the market. GVK calls ...

    Comment?

  5. Intramuscular Drug Delivery Market & Pipeline Landscape Analysed by...Read the original story w/Photo

    Wednesday Jan 28 | PRWeb

    The R&D of intramuscular drug delivery has gathered speed in the pharma universe over the last few decades. The excellent safety and efficacy profiles along with familiarity are the key factors for investing more funds in the segment.

    Comment?

  6. New market study, "PLIVA d.d. - Strategic SWOT Analysis Review", has been publishedRead the original story

    Wednesday Jan 28 | PR-inside.com

    PLIVA d.d. is Croatia-based pharmaceutical company. PLIVA is a subsidiary of Teva Pharmaceutical Industries Limited.

    Comment?

  7. Indian stock market and companies daily reportRead the original story

    Wednesday Jan 28 | Stock Market Review

    ... - 8,787 levels. Cipla- Update The U.S. Food and Drug Administration (USFDA) said it approved Teva Pharmaceutical Industries Ltd's first generic equivalent to Nexium (esomeprazole magnesium) Delayed-Release Capsules in the United States, the agency's ...

    Comment?

  8. U.S. Supreme Court Grants Shire PetitionRead the original story

    Tuesday Jan 27 | BioSpace

    Shire plc today announced that the U.S. Supreme Court granted Shire's petition in the Shire v. Watson patent case regarding LIALDA .

    Comment?

  9. Still looking to buy, Pfizer revenue, profit hit by currency-exchange ratesRead the original story w/Photo

    Tuesday Jan 27 | Philly.com

    Chief executive officer Ian Read said Tuesday that Pfizer will keep looking for companies to buy and is taking the next steps to see whether its pieces are worth more than the sum of its parts. Pfizer has said that it tried to buy AstraZeneca in 2014, and it reportedly inquired about buying Actavis and Teva Pharmaceutical Industries Ltd. AstraZeneca, Teva, and Actavis all have operations in the Philadelphia region.

    Comment?

  10. Pfizer's Deal Desires Move From Drug Pipeline to ProductsRead the original story

    Tuesday Jan 27 | The Washington Post

    ... the industry's biggest-ever acquisition, the drugmaker has looked at other options including Teva Pharmaceutical Industries Ltd. and Actavis Plc, according to people familiar with the matter. It's also exploring a breakup into two or three separate ...

    Comment?

  11. Pfizer Forecast Falls Short on Patent Expiration, CurrencyRead the original story

    Tuesday Jan 27 | The Washington Post

    ... $120 billion deal to acquire AstraZeneca Plc last year, eyed Actavis Plc and reached out to Teva Pharmaceutical Industries Ltd., people familiar with the matter have said. AstraZeneca was attractive partly because of the U.K. company's oncology ...

    Comment?

  12. Pfizer's Deal Desires Move From Pipeline to ProductsRead the original story

    Tuesday Jan 27 | The Washington Post

    ... the industry's biggest-ever acquisition, the drugmaker has looked at other options including Teva Pharmaceutical Industries Ltd. and Actavis Plc, according to people familiar with the matter. It's also exploring a breakup into two or three separate ...

    Comment?

  13. Why ANI Pharmaceuticals Is A Strong BuyRead the original story w/Photo

    Tuesday Jan 27 | Seeking Alpha

    The company has been active with product acquisitions lately and there are indications that this trend will continue going forward. ANI Pharmaceuticals has transformed itself over the last 18 months.

    Comment?

  14. Pfizer's revenue and profit declines in fourth quarter and all of 2014Read the original story w/Photo

    Tuesday Jan 27 | Philly.com

    ... of lowering their U.S. tax bill. More recently, Bloomberg reported that Pfizer approached Teva Pharmaceutical Industries, Ltd., about buying the Israel-based drugmaker, but was rebuffed. Teva has several facilities in the Philadelphia region. It's ...

    Comment?

  15. FDA Approves Teva's Generic NexiumA Delayed-Release CapsulesRead the original story w/Photo

    Tuesday Jan 27 | Pharmaceutical Processing

    Teva Pharmaceutical has announced the Food and Drug Administration approval of the first generic equivalent to Nexium Delayed-Release Capsules in the United States. Teva is preparing to launch the product in the near future.

    Comment?

  16. What Investors Should Do About Imminent Obesity Drug Approvals In EuropeRead the original story w/Photo

    Tuesday Jan 27 | Seeking Alpha

    Investors should consider whether treatment choices for obesity and type 2 diabetes will become coupled, thus impacting drug choice and therefore revenues of multiple classes of drugs. been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use [CHMP] of the European Medicines Agency [EMA] for obesity.

    Comment?

  17. Teva Set To Launch Generic Nexium, Outlook PositiveRead the original story w/Photo

    Tuesday Jan 27 | Seeking Alpha

    Teva stands to generate significant revenues from generic Nexium. The company should see an earnings boost following the upcoming launch of the generic.

    Comment?

  18. Pfizer Beats Earnings Estimates as Vaccine Sales IncreaseRead the original story

    Tuesday Jan 27 | Bloomberg

    ... deal to acquire AstraZeneca Plc (AZN) last year, eyed Actavis Plc (ACT) and reached out to Teva Pharmaceutical Industries Ltd. (TEVA) , people familiar with the matter have said. AstraZeneca was attractive partly because of the U.K. company's ...

    Comment?

  19. FDA Backs Teva Pharmaceutical Industries Limited's Generic Nexium in...Read the original story

    Monday Jan 26 | BioSpace

    Teva Pharmaceutical Industries Ltd. announces the Food and Drug Administration approval of the first generic equivalent to Nexium Delayed-Release Capsules in the United States. Nexium Delayed-Release Capsules, marketed by AstraZeneca, had annual sales of approximately $6 billion in the United States, according to IMS data as of November 2014.

    Comment?

  20. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Monday Jan 26 | Business Wire

    ... has announced the addition of the "Global Solar Charger Industry Report 2015" report t... )--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the Food and Drug Administration (FDA) approval of the first generic equivalent to Nexium ...

    Comment?